Anest. intenziv. Med. 2025;36(5):357-359 | DOI: 10.36290/aim.2025.068

Year 2025 in review - Chronic pain therapyReview Article

Fricová J.
Klinika anesteziologie, resuscitace a intenzivní medicíny, Centrum pro léčbu bolesti 1. lékařské fakulty Univerzity Karlovy a Všeobecné fakultní nemocnice, Praha

Year 2025 introduces major advancements in neurobiological concepts of chronic pain, particularly through the identification of dopaminergic modulation as a novel therapeutic framework. This article summarises key developments in international initiatives, pharmacotherapy, non‑pharmacological interventions, clinical guidelines and neurobiological mechanisms of pain. It follows the structure and style of the 2024 overview and highlights how new insights are shaping current and future pain management.

Keywords: chronic pain, dopaminergic modulation, nociplastic pain, neuromodulation, tDCS, rTMS, PRT, pharmacotherapy.

Received: December 17, 2025; Accepted: December 17, 2025; Published: December 22, 2025  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Fricová J. Year 2025 in review - Chronic pain therapy. Anest. intenziv. Med. 2025;36(5):357-359. doi: 10.36290/aim.2025.068.
Download citation

References

  1. International Association for the Study of Pain (IASP). Global Year for Sex and Gender Differences in Pain. IASP; 2024.
  2. European Pain Federation (EFIC). European Pain Awareness Campaigns and Policy Statements. EFIC; 2024.
  3. U.S. Food and Drug Administration (FDA). Cannabidiol (CBD) - Regulation, Safety and Efficacy in Pain. FDA Safety Communication; 2024-2025.
  4. American Academy of Pediatrics. Clinical Practice Guideline for Opioid Prescribing in Children and Adolescents With Acute Pain. AAP; 2024.
  5. Geha P, Sulovari A, Freeman R, Gewandter JS. Dopaminergic modulation: revisiting a promising novel pathway for pharmacologic treatment of chronic pain. Pain. 2025 Oct 1;166(10):2213-2219. doi: 10.1097/j.pain.0000000000003598. Go to original source... Go to PubMed...
  6. Neuromodulation Research Consortium. Non‑invasive brain stimulation (tDCS, rTMS) in nociplastic and musculoskeletal pain: multicentre clinical data 2024-2025.
  7. Psychological Interventions Working Group. Pain Reprocessing Therapy and Personal Danger Signal Reprocessing in chronic pain: outcome evidence 2024-2025.
  8. Nav1.7 Genetic Variants and Chronic Pain: Clinical Implications. Expert Consensus Report; 2024-2025.




Anesteziologie a intenzivní medicína

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.